𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Topology of hepatitis C virus envelope glycoproteins

✍ Scribed by Anne Op De Beeck; Jean Dubuisson


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
154 KB
Volume
13
Category
Article
ISSN
1052-9276

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hepatitis C virus encodes two envelope glycoproteins, E1 and E2, that are released from a polyprotein precursor after cleavage by host signal peptidase(s). These proteins contain a large N‐terminal ectodomain and a C‐terminal transmembrane domain, and they assemble as a noncovalent heterodimer. The transmembrane domains of hepatitis C virus envelope glycoproteins have been shown to be multifunctional: (1) they are membrane anchors, (2) they bear ER retention signals, (3) they contain a signal sequence function, and (4) they are involved in E1‐E2 heterodimerisation. Due to these multiple functions, the topology adopted by these transmembrane domains has given rise to much controversy. They are less than 30 amino acid residues long and are composed of two stretches of hydrophobic residues separated by a short segment containing one or two fully conserved positively charged residues. The presence of a signal sequence function in the C‐terminal half of the transmembrane domains of E1 and E2 had suggested that these domains are composed of two membrane spanning segments. However, the two hydrophobic stretches are too short to make two membrane spanning α‐helices. These discrepancies can now be explained by a dynamic model, based on experimental data, describing the early steps of the biogenesis of hepatitis C virus envelope glycoproteins. In this model, the transmembrane domains of E1 and E2 form a hairpin structure before cleavage by a signal peptidase, and a reorientation of the second hydrophobic stretch occurs after cleavage to produce a single membrane spanning domain. Copyright Β© 2003 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Isolation and characterization of human
✍ da Silva Cardoso, Marcia; Siemoneit, Karl; Sturm, Daniela; Krone, Christoph; Mor πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 590 KB

The isolation and characterization of human monoclonal antibodies (humAbs) against the hepatitis C Virus (HCV) glycoproteins E1 and E2 are described. B-cells from blood donors with anti-HCV were transformed with Epstein-Barr virus. The supernatants of the resulting lymphoblastoid clones were screene

Quantitative analysis of antibody to hep
✍ N Yuki; N Hayashi; A Kasahara; H Hagiwara; E Mita; K Ohkawa; K Katayama; H Fusam πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 2 views

The significance of circulating antibody to hepatitis C HCV E1 corresponds to the pestiviral gp33/gp25 envevirus (HCV) envelope glycoprotein 2 (E2)/nonstructural lope glycoprotein and the flaviviral envelope protein protein 1 (NS1) glycoprotein was studied in 83 patients (M/E), whereas E2/NS1 corres

Structural stability of hepatitis C viru
✍ Feng He; Sangeeta B. Joshi; Fons Bosman; Marijke Verhaeghe; C. Russell Middaugh πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 425 KB

The hepatitis C virus (HCV) envelope glycoprotein E1 has been widely employed as a potential vaccine antigen in clinical research. A truncated form (amino acids 192-326) of the E1 protein (E1y) was expressed in the yeast Hansenula polymorpha and purified from the cell lysate. E1y forms protein parti